COVID-19 protection for your employees
Solutions for working in the new normal.
Infection protection of employees
The coronavirus pandemic resulted in an unprecedented global lockdown. A life-threatening shock that has changed the workplace and will have a lasting effect. The risk of another pandemic is a new reality that affects all areas of life and work. The negative consequences of the worldwide lockdown exceed all economic crises of the last decades. There is a time before Corona and a “new” Normal with Corona, in which the protection of employee health is central.
Despite existing SARS-CoV-2 safety standards, many employees still feel insecure and prefer to stay in their home office. We offer effective COVID-19 tests to increase employee safety at the workplace during times of the new normal.
„New Corporate Health Management and Employee Health Protection in Context of COVID-19”Patrick Hofmann and Prof. David Matusiewicz
ANTIBODY RAPID TEST
Sale of validated COVID-19 antibody rapid tests
- Proof of achievement based on scientific studies, certificates, approvals
- Qualified review of performance data in consultation with experts and physicians
- Regular and punctual delivery of the required test kits
Development of a company-specific test concept
- Analysis of the organizational structure: Employees and locations
- Development of an optimal test frequency
- Coordination with management and works council
Implementation of the regular test concept in operation
- Determination of internal processes, responsibility and operating instructions
- Professional application in consultation with the company doctor
- Training and communication of the test concept
In addition, we offer: Preparation of tailor-made pandemic plans
- Prevention - Detection - Management
- Definition of measures
- Training of employees
- Phone-consultation if necessary
ANTIBODY RAPID TEST
About our Test
IN ORDER TO IMPLEMENT ANTIBODY RAPID TESTS, IT IS CRUCIAL TO ENSURE QUALITY AND PRECISION.
- IgM and IgG immunity detection with up to 99.99% accuracy
- Certification of quality by scientific studies
- Certificates and accreditation (CE and ISO certification, FDA EUA accreditation)
- Simple and professional on-site application; without sample collection by a physician and without a medical laboratory
- Test result available within 10 min
- More cost-effective than comparable laboratory tests
How our covid-19 test works
Possible results of a covid-19 rapid test
Internal procedural control "C"; correct result only with color display
IgM positive is a sign of a possible infection. On medical orders, if applicable, virus detection by PCR test
IgM/IgG positive are signs of a possible infection. Virus detection by PCR test
IgG positive is a sign of a passing infection; there is a very high probability of transient immunity
Dr. med. Jens Tülsner, MD
Managing Director Marine Medical Solutions
Maintaining the health of the crew and guests in all areas of the "mobility" sector (tourism, logistics, transport) creates special conditions and requirements. MMS specializes in finding and supporting solutions - from concept to implementation, from consulting to management. Comprehensive industry know-how and years of experience in medicine guarantee customers safety, efficiency and cost savings.
Dr. med. Jörg Ansorg, MD
Managing Director meduplus
meduplus comes from active patient care and at the same time has decades of experience as a trainer in further and advanced medical education. At meduplus, medical background is combined with know-how in new media and mobile communication. On this basis, meduplus develops new learning opportunities for physicians, nurses and medical professionals together with specialist experts, didactics and educators as well as IT specialists.
Frequently Asked Questions
Detection of COVID-19 Infections
1How long does infectiousness or risk of infection exist?
The average infectiousness lasts about 8-9 days. Based on real data, the RKI estimates that relevant infectiousness is already present two days before the onset of symptoms, and the highest infectiousness is on the day before the onset of symptoms. Therefore, early infections may be detected too late, after other people may already have been infected. The COVID-19 App of the German Federal Government is intended to enable a later follow-up of potential infections by the health authorities.
2When are COVID-19 PCR tests used for pathogen detection?
Up to now, a medical PCR laboratory test has been carried out in the case of justified suspicion or symptoms of acute infections. In the case of positive test results, chains of infection are tracked and interrupted by the Federal Government's corona app to prevent them from spreading. In addition, tests for returnees are offered at airports.
3What should be done in case of acute symptoms or a well-founded suspicion?
Employees with acute COVID-19 symptoms or with a well-founded suspicion should consult a doctor. If in doubt, employees should not come to the office until it has been clarified whether it is a COVID-19 infection or after a two-week domestic quarantine.
4How is an acute infection determined?
An acute infection is diagnosed by direct pathogen detection using a PCR pathogen test, which is primarily carried out by a specialist medical laboratory on a doctor's order. The viral genome is detected using highly sensitive molecular test systems (real-time PCR). The real test time is about 4 to 5 hours. The time between taking the sample and reporting the results can be one to two days, depending on the number of samples, the reporting of results can take longer. In the early phase, smears from the upper respiratory tract are particularly suitable as sample material (throat swabs or nasopharyngeal swabs).
5How are pathogens and antibodies related?
PCR pathogen detection using a mouth-nose swab is used to detect an acute COVID-19 infection. In the course of an infection, the pathogens decrease and specific COVID-19 antibodies are formed as a defense reaction of the body, which very probably leads to a temporary immunity.
Significance of COVID-19 Antibody Rapid Tests
1What do antibodies say?
Antibodies are usually formed from the end of the 2nd week in the course of an infection as a defensive reaction of the body, which very probably leads to a temporary immunity. Antibody rapid tests refer exclusively to COVID-19 antibodies, formed only in the course of an infection and have a temporary immunizing effect after an infection has been overcome. At this stage, it is still unclear how regularly, robustly and permanently this immune status is built up.
2Why are antibody rapid tests important?
Antibody tests provide reliable IgG evidence of whether a COVID-19 infection has already occurred, and a temporary immunity exists. A COVID-19 infection leads to mild and asymptomatic courses in about 80% of cases and often remains undetected. Therefore, there is a high under-coverage (estimated number of unreported cases about 10-20x higher).
3What is the accuracy of antibody rapid tests?
The quality of results is increased up to 99.99% by a repeated antibody test, reducing the risk of false positive IgG detection from 1:100 to up to 1:10,000. Temporary immunity is detected by an IgG-positive test result. The IgG accuracy of high-quality rapid tests is 98.5-99.0%; probability that immunity is correctly indicated. In practice, a positive test result is followed by a second rapid test for confirmation. This procedure increases the IgG accuracy to up to 99.99%.
4What does a positive IgM antibody mean?
The IgM antibody is formed as an early immune response of the body after a COVID-19 infection. The one-time detection of IgM antibody does not indicate an acute infection with certainty. The assessment of whether the detection indicates an acute infection must be made by the diagnostic laboratory within the laboratory medical findings framework utilizing PCR pathogen detection, taking into account the characteristics of the tests used in each case, any preliminary examinations carried out, and any anamnestic information.
5What does a positive IgG antibody mean?
Immunized employees are IgG positive and have already been through an infection. These employees are most likely temporarily immune. Experience with other coronavirus diseases (SARS and MERS) suggests that immunity could last up to three years. To determine this more accurately, longitudinal studies are needed that observe patients' immunity over a more extended period of time. Based on animal experiments, earlier findings on SARS, and plausibility assumptions, experts assume that recovered patients have only a very low risk of reinfection.
6What does a negative antibody test mean?
Employees who have not undergone COVID-19 infection are tested negative for antibodies. For these persons, there is still a risk of infection and contagion. Based on the SARS-CoV-2 occupational safety standards, employees can work with restrictions; persons in the risk groups should remain in the home office if necessary. In any case, employees who show symptoms or have a justified suspicion of infection should not return to the workplace and consult a doctor.
7Is there COVID-19 immunity?
Experience with other coronavirus diseases (SARS and MERS) suggests that immunity could last up to three years. To determine this more accurately, longitudinal studies are needed that observe patients' immunity over a more extended period of time. Based on animal experiments, previous findings on SARS, and plausibility assumptions, experts assume that recovered patients have only a very low risk of reinfection.
8What limitations do rapid antibody tests have?
Antibody rapid tests do not detect the presence of an acute COVID-19 infection. Antibody rapid tests provide a qualitative result about the presence of COVID-19 IgM/IgG antibodies, which can be detected for about 2 weeks of infection. It is still unclear at this point in time how regularly, robustly and permanently this immune status is built up, so that immunized IgG-positive employees should be tested regularly on a monthly basis to determine whether IgG antibodies can still be detected.
9What is the difference between antibody rapid test and antibody laboratory test?
The IgG accuracy of 98.5-99.0% of high-quality rapid tests is comparable to the accuracy of the ELISA laboratory test. For COVID-19 antibody rapid tests, a drop of blood from the fingertip is sufficient to detect antibodies easily and quickly (in 10 minutes). For COVID-19 antibody laboratory test, blood is taken from the vein and analyzed in the laboratory (at least 1-2 days). In contrast to the rapid test, the laboratory test requires a doctor and/or a laboratory physician.
Operational use of preventive COVID-19 antibody rapid tests
1What is the immunity status of the staff?
The vast majority of the workforce still has no immune protection against SARS-CoV-2. So far, only a small proportion of people have been infected with SARS-CoV-2 and are - probably and at least for some time - immune to the virus. It is still unclear at this point in time how regularly, robustly and permanently this immune status is built up.
2Why do the majority of infections remain undetected?
Most, about 80% of nCoV-2 infections show mild or asymptomatic courses similar to influenza or the common cold and, therefore, often remain undetected (the number of undetected cases is probably 10-20 times higher than the number of confirmed infections). A prevention strategy must take into account both possible acute cases and mild courses, as the pathogen is often only detected in symptomatic courses in the early phase of infection.
3Why do rapid tests for antibodies offer additional protection at the workplace?
After an infection, antibodies are formed, which most likely create a temporary immunity. These employees have a low risk of reinfection and infection, and could return to their workplace, start traveling, and come into contact with customers. Antibodies Rapid tests identify immunized employees who are very unlikely to present a risk of infection to other employees. It is not yet clear how regularly, robustly, and permanently this immune status is built up, so these employees should be tested for antibodies on a monthly basis.
4Why should rapid tests for antibodies be used in the company?
Antibody rapid tests provide certainty about the immune status of employees and optimize protection at the workplace in the "New Normal". Asymptomatic courses remain too often undetected. The darkroom of immunized employees is about 10-20 times the number of detected infections. Immunized employees have a low risk of reinfection and infection for other people. The SARS-CoV-2 occupational safety standards of the Federal Ministry of Labor and Social Affairs form the operational basis, but do not offer absolute protection against COVID-19.
5What additional safety do rapid tests for antibodies provide in the workplace?
Many employees are unsure whether they have already been infected. Antibody rapid tests are used to identify immunized employees who have already been infected. These employees are very likely to be temporarily immune and have a low risk of reinfection and infection. Immunized employees can participate in everyday work with greater security. As a rule, antibodies are detectable from the 2nd week after the onset of symptoms. It is not yet clear how regularly, robustly, and permanently this immune status is built up, so that immunized employees should continue to be tested regularly on a monthly basis.
6Why are antibody rapid tests important in the company?
The optimal protection of employees requires a differentiated approach. Here, the following groups of employees must be distinguished. Immunized employees are IgG positive and can return to work. Employees - without symptoms who test negative for antibodies can continue to work in compliance with occupational safety standards. Employees - without symptoms, who test IgM positive, contact their doctor immediately. The same applies to employees - with symptoms, who can receive PCR pathogen detection on doctor's orders.
7What are the advantages of rapid antibody tests for employers?
Immunized employees have a lower risk of reinfection and infection and can be reinstated in their daily work. Due to the high number of unreported cases, employees are also tested for antibodies whose infection has not been detected. Antibody rapid tests help to reduce uncertainty and increase the productivity of immunized employees in the workplace. As the population becomes increasingly infected, the number of immunized employees who can be used more safely in the workplace increases further. It is still unclear at this stage how regularly, robustly and permanently this immune status is built up, so that immunized IgG-positive employees should continue to be tested regularly on a monthly basis to determine whether IgG antibodies can be detected.
8What are the advantages of rapid antibody testing for employees?
Employees are unsure whether they themselves or others have been infected with COVID-19 and are now immune. Asymptomatic and mild courses are similar to the common flu and, therefore, often remain undetected. A positive IgG-antibody test confirms a temporary immunity after a passed infection. Immunized workers have a low risk of reinfection and infection. Workers and their families have an increased need for safety and welcome the introduction of rapid antibody testing in the workplace. It is still unclear at this stage how regularly, robustly and permanently this immune status is built up so that immunized IgG-positive employees should continue to be tested regularly on a monthly basis to determine whether IgG antibodies can be detected.
9Who should be involved in the decision on antibody rapid tests in the company?
The introduction and regular implementation require the organizational involvement of stakeholders such as management, work council or employee representatives, company doctor, and employees. A common approach based on consensus promotes acceptance within the company. It is a voluntary offer for employees.
10How are antibody rapid tests introduced in the company?
First, a site-specific test concept must be developed and approved. This is the basis for the training of company users by physicians and communication with employees. The performance of the test and documentation of the results is voluntary and is subject to the approval of the employees.
11How often should employees be tested for antibodies?
The test frequency varies with the risk assessment of the workplace. The frequency of changing contacts, the extent of travel, the nature, and importance of the workplace for the maintenance of the business as well as private circumstances (family celebrations) must be taken into account. A regular test offer with a weekly or monthly minimum frequency creates a reliable basis. A test office, which is open daily at certain times, offers employees the opportunity to carry out additional tests depending on the situation.
12How are antibody rapid tests used in everyday work?
Antibody Rapid Tests are IVD medical devices that require professional application. For this purpose, qualified employees (e.g., first-aiders) must be trained in the application and evaluation of the antibody rapid test. Employees are basically free to decide whether they wish to be tested. The test and the release of the data are voluntary.
13What does the professional application of the antibody rapid tests mean in the company?
It is necessary that the company users (e.g., first aiders) are professionally trained by physicians, that a site-specific test concept is developed and that the results are documented and communicated. A professional application in the operational environment is an absolute prerequisite for the use of antibody rapid tests.
Costs and benefits of preventive COVID-19 antibody rapid tests
1What have our infection control measures achieved so far?
We have succeeded in flattening the first COVID-19 wave in Germany. The decisive factors were the rapid and extensive infection control measures and the good cooperation of the population. However, this by no means that the pandemic in Germany is over. There is a risk of a second wave in autumn/winter 2020/2021. There is no absolute protection against COVID-19, but rather it is a matter of doing what is possible to protect employees.
2Which protective measures are effective in reducing the risk of transmission?
The rapid isolation of positively tested cases, the identification and early quarantine of close contact persons, the keeping of distance from other people, the observance of hygiene rules, and the wearing of (every day) masks (AHA rule) are effective measures for reducing the risk of transmission. The SARS-CoV-2 occupational safety standards of the Federal Ministry of Labor and Social Affairs form an operational basis.
3Can a second COVID-19 wave occur?
The key question is whether the solidarity-based responsibility of the population to comply with the extensive infection prevention measures will continue. It must be expected that the number of cases may increase again and that a second COVID-19 wave may occur. The risk factors are manifold, for example, due to infections introduced by holidaymakers or business travelers.
4How long do rapid tests for antibodies take?
As long as no vaccine is available, COVID-19 will continue to spread, and the natural immunization of society will progress. The 10-20 times higher number of unreported cases is due to asymptomatic courses that have gone undetected. Antibody rapid tests are used for the successful identification of immunized employees who can return to work with greater certainty.
5What happens when a vaccine is available?
It is currently difficult to estimate if and when an effective vaccine will be available to the population on a nationwide basis. It remains to be seen how sustainable the vaccine will be, whether immunity will be permanent or temporary. Some experts and politicians predict a rapid development so that the vaccine could possibly be available as early as mid-2021.
6How much does the introduction of rapid tests for antibodies cost?
The cost of regular monthly tests for all employees is approximately 0.5% of the payroll. The expenses include the test and professional applications in the company. DNA4GOOD offers an all-round offer of test plus service for professional application in the company. On the Internet, you can find offers for rapid antibody tests, which vary greatly with the quality of the tests and do not include any professional application service.
7What does an operational implementation cost?
The running costs for regular antibody rapid tests vary with the test frequency. The costs for monthly or weekly tests of the staff are about 0.5 or up to 2% of the wage bill. There are no additional external costs for professional applications by internal resources (e.g., first aiders). DNA4GOOD offers an all-inclusive test plus service for professional applications in the company.
8Why is the health protection of employees necessary also in the future?
The preventive health protection of employees plays a decisive role in order to be better prepared for future pandemics. The global COVID-19 pandemic is a so-called "black swan," an unlikely event with devastating consequences for society and the economy that threaten the existence of the company. The risk of a repeated lockdown is a new operational reality and requires new, sustainable health protection of employees in the workplace in the new normality.